Clinical Profile and Prognosis of Patients With Acute Decompensated Heart Failure Who Met the Obesity-Related Eligibility for Subcutaneous Semaglutide - Findings From the CURE-HF Registry.

Nishikawa K, Minamisawa M, Yoshie K, Suzuki S, Tanaka K, Okuma Y, Kimura K, Ueki Y, Oguchi Y, Kato T, Saigusa T, Ebisawa S, Okada A, Motoki H, Kuwahara K

Open source

DOI
10.1253/circrep.cr-25-0041
Published
2025 Jun 10
Container
Circulation reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1253/circrep.cr-25-0041,
  title = {Clinical Profile and Prognosis of Patients With Acute Decompensated Heart Failure Who Met the Obesity-Related Eligibility for Subcutaneous Semaglutide - Findings From the CURE-HF Registry.},
  author = {Nishikawa K and Minamisawa M and Yoshie K and Suzuki S and Tanaka K and Okuma Y and Kimura K and Ueki Y and Oguchi Y and Kato T and Saigusa T and Ebisawa S and Okada A and Motoki H and Kuwahara K},
  year = {2025},
  journal = {Circulation reports},
  doi = {10.1253/circrep.cr-25-0041},
  url = {https://doi.org/10.1253/circrep.cr-25-0041}
}

RIS

TY  - JOUR
TI  - Clinical Profile and Prognosis of Patients With Acute Decompensated Heart Failure Who Met the Obesity-Related Eligibility for Subcutaneous Semaglutide - Findings From the CURE-HF Registry.
AU  - Nishikawa K
AU  - Minamisawa M
AU  - Yoshie K
AU  - Suzuki S
AU  - Tanaka K
AU  - Okuma Y
AU  - Kimura K
AU  - Ueki Y
AU  - Oguchi Y
AU  - Kato T
AU  - Saigusa T
AU  - Ebisawa S
AU  - Okada A
AU  - Motoki H
AU  - Kuwahara K
PY  - 2025
JO  - Circulation reports
DO  - 10.1253/circrep.cr-25-0041
UR  - https://doi.org/10.1253/circrep.cr-25-0041
ER  - 

APA

K, N., M, M., K, Y., S, S., K, T., Y, O., K, K., Y, U., Y, O., T, K., T, S., S, E., A, O., H, M., & K, K. (2025). Clinical Profile and Prognosis of Patients With Acute Decompensated Heart Failure Who Met the Obesity-Related Eligibility for Subcutaneous Semaglutide - Findings From the CURE-HF Registry.. Circulation reports. https://doi.org/10.1253/circrep.cr-25-0041

Source records